XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -6.60%12.04B | -15.24%3.39B | -12.09%3.57B | -7.02%3.02B | 30.45%2.05B | 65.92%12.89B | 46.15%4B | 63.64%4.06B | 45.50%3.25B | 402.56%1.57B |
Net income from continuing operations | 4.41%10.79B | 4.38%2.79B | -11.82%2.46B | -8.31%2.68B | 46.96%2.85B | 54.12%10.33B | 83.84%2.67B | 36.91%2.79B | 74.78%2.92B | 26.35%1.94B |
Operating gains losses | -97.89%10M | -58.76%-154M | --0 | --228M | -111.19%-64M | 178.38%475M | ---97M | --0 | --0 | --572M |
Depreciation and amortization | 0.42%2.15B | 1.83%555M | 3.43%543M | -2.03%531M | -1.50%524M | -3.38%2.14B | -2.33%545M | -4.72%525M | -1.99%542M | -4.49%532M |
Deferred tax | -4.90%-621M | -102.78%-292M | -110.75%-196M | 51.83%-79M | 71.73%-54M | -57.03%-592M | -414.29%-144M | -40.91%-93M | 10.87%-164M | -92.93%-191M |
Other non cash items | 50.40%564M | 101.76%343M | 17.17%116M | 1,100.00%110M | -104.27%-5M | -46.50%375M | -70.12%170M | 19.28%99M | -110.89%-11M | 325.00%117M |
Change In working capital | -668.87%-859M | -82.36%151M | -12.64%643M | -971.43%-450M | 14.01%-1.2B | 108.39%151M | 743.61%856M | 679.53%736M | -146.67%-42M | 14.17%-1.4B |
-Change in receivables | 63.39%-160M | -10.17%-130M | 47.26%215M | -20.59%-164M | 75.38%-81M | -98.64%-437M | 79.83%-118M | 78.05%146M | -120.76%-136M | 11.56%-329M |
-Change in inventory | -13.74%-414M | -65.38%367M | -201.47%-138M | -29.94%-204M | 68.71%-439M | 85.94%-364M | 112.42%1.06B | 112.53%136M | 83.83%-157M | -35.95%-1.4B |
-Change in payables and accrued expense | -185.98%-454M | -35.59%304M | 23.15%250M | -2.43%281M | -196.32%-1.29B | -56.18%528M | 41.32%472M | -79.05%203M | -41.10%288M | 25.89%-435M |
-Change in other current assets | -2.11%-97M | 2.69%-217M | 112.77%100M | -53.85%-40M | -43.93%60M | 54.76%-95M | 16.48%-223M | 262.07%47M | -100.00%-26M | 8.08%107M |
-Change in other current liabilities | -123.69%-104M | -166.34%-67M | 389.29%81M | -650.00%-385M | -9.80%267M | 158.22%439M | 177.10%101M | 90.70%-28M | 125.64%70M | 704.08%296M |
-Change in other working capital | 362.50%370M | 75.69%-106M | -41.81%135M | 176.54%62M | -23.56%279M | -89.58%80M | -2,664.71%-436M | -2.11%232M | -139.90%-81M | 17.36%365M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -6.60%12.04B | -15.24%3.39B | -12.09%3.57B | -7.02%3.02B | 30.45%2.05B | 65.92%12.89B | 46.15%4B | 63.64%4.06B | 45.50%3.25B | 402.56%1.57B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 58.22%-2.45B | -197.65%-1.65B | 69.72%-1.04B | 39.78%-722M | 240.26%958M | -131.05%-5.87B | 34.28%-554M | -1,907.89%-3.44B | -108.52%-1.2B | 47.98%-683M |
Capital expenditure reported | -3.98%-3.22B | -21.43%-1.04B | 7.43%-723M | -1.70%-719M | 1.87%-736M | -18.97%-3.09B | -20.62%-854M | -26.58%-781M | -18.82%-707M | -10.46%-750M |
Net PPE purchase and sale | -7.55%722M | -16.97%181M | 2.05%199M | 1.63%187M | -15.76%155M | -5.90%781M | 32.93%218M | -1.52%195M | -7.54%184M | -31.60%184M |
Net business purchase and sale | -1,425.00%-61M | -40.00%6M | ---6M | ---103M | 400.00%42M | -500.00%-4M | --10M | --0 | --0 | ---14M |
Net investment purchase and sale | 162.80%1.63B | -169.29%-291M | 95.70%-102M | 228.23%427M | 627.15%1.59B | -231.07%-2.59B | 200.24%420M | -504.43%-2.37B | -344.00%-333M | 65.49%-302M |
Net other investing changes | -57.70%-1.53B | -45.98%-508M | 14.11%-408M | -49.85%-514M | -147.74%-95M | -10,844.44%-967M | -390.00%-348M | -2,259.09%-475M | -226.67%-343M | 810.71%199M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 58.22%-2.45B | -197.65%-1.65B | 69.72%-1.04B | 39.78%-722M | 240.26%958M | -131.05%-5.87B | 34.28%-554M | -1,907.89%-3.44B | -108.52%-1.2B | 47.98%-683M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -37.98%-9.57B | 85.95%-426M | 13.57%-1.21B | -110.27%-2.93B | -352.08%-5B | 4.79%-6.93B | -170.08%-3.03B | 38.24%-1.4B | 35.98%-1.39B | 35.51%-1.11B |
Net issuance payments of debt | 34.51%799M | 121.96%930M | 159.76%248M | -175.27%-490M | 281.97%111M | 191.10%594M | 10.85%419M | -68.70%-415M | 227.15%651M | 77.57%-61M |
Net common stock issuance | -54.68%-7.68B | 77.24%-635M | -140.68%-775M | -26.51%-1.8B | -950.12%-4.46B | -18.76%-4.96B | -219.95%-2.79B | 76.78%-322M | -33.02%-1.43B | 49.88%-425M |
Cash dividends paid | -3.24%-2.65B | -2.72%-680M | -3.02%-683M | -2.75%-635M | -4.52%-648M | -5.04%-2.56B | -6.77%-662M | -4.74%-663M | -4.39%-618M | -4.20%-620M |
Net other financing activities | ---41M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -37.98%-9.57B | 85.95%-426M | 13.57%-1.21B | -110.27%-2.93B | -352.08%-5B | 4.79%-6.93B | -170.08%-3.03B | 38.24%-1.4B | 35.98%-1.39B | 35.51%-1.11B |
Net cash flow | ||||||||||
Beginning cash position | -0.40%6.99B | -13.95%5.65B | -41.20%4.35B | -26.94%4.97B | -0.40%6.99B | -24.29%7.01B | 3.23%6.56B | 22.76%7.39B | 4.04%6.8B | -24.29%7.01B |
Current changes in cash | -79.27%17M | 216.83%1.32B | 270.19%1.32B | -195.89%-630M | -821.30%-1.99B | 103.99%82M | -46.18%416M | -291.83%-775M | 226.83%657M | 92.04%-216M |
Effect of exchange rate changes | 3.64%-106M | -844.44%-67M | 62.71%-22M | 122.03%13M | -2,900.00%-30M | 43.30%-110M | 107.83%9M | 18.06%-59M | -755.56%-59M | 93.75%-1M |
End cash Position | -1.27%6.9B | -1.27%6.9B | -13.95%5.65B | -41.20%4.35B | -26.94%4.97B | -0.40%6.99B | -0.40%6.99B | 3.23%6.56B | 22.76%7.39B | 4.04%6.8B |
Free cash flow | -9.94%8.82B | -25.18%2.36B | -13.21%2.85B | -9.44%2.3B | 59.90%1.32B | 89.53%9.79B | 55.05%3.15B | 75.91%3.28B | 55.19%2.54B | 324.86%823M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |